TSXV - Delayed Quote CAD
Arch Biopartners Inc. (ARCH.V)
1.7200
+0.0200
+(1.18%)
At close: May 9 at 3:54:42 PM EDT
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Cash Flows from Used in Operating Activities Direct
-2,687.8880
-2,331.1700
-234.0750
479.4760
-2,980.7430
Financing Cash Flow
2,440.1030
1,502.8670
559
-421.3700
2,775.3000
End Cash Position
54.8490
2.9700
831.2730
506.3480
448.2420
Issuance of Capital Stock
1,809.4070
1,362.5000
128
369.9300
1,045.8000
Issuance of Debt
360.5140
350
1,500
0
2,200
Repayment of Debt
--
0
-1,000
-775
-425
Free Cash Flow
-2,687.8880
-2,331.1700
-234.0750
479.4760
-2,980.7430
9/30/2021 - 5/7/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAGLE.ST Magle Chemoswed Holding AB (publ)
28.40
+1.43%
TELI.CN Telescope Innovations Corp.
0.2450
-7.55%
CVALF Covalon Technologies Ltd.
1.8800
0.00%
IOT.V Innovotech Inc.
0.1400
-3.45%
TELIF Telescope Innovations Corp.
0.1850
0.00%
NRX.V NurExone Biologic Inc.
0.6600
-2.94%
IMRN Immuron Limited
1.9100
-2.05%
MIR.V MedMira Inc.
0.0850
0.00%
COV.V Covalon Technologies Ltd.
2.6300
+2.73%
UPB Upstream Bio, Inc.
8.82
-0.23%